Bladder cancer
O Sanli, J Dobruch, MA Knowles, M Burger… - Nature reviews Disease …, 2017 - nature.com
Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
Advances in diagnosis and treatment of bladder cancer
A Lopez-Beltran, MS Cookson, BJ Guercio, L Cheng - bmj, 2024 - bmj.com
Bladder cancer remains a leading cause of cancer death worldwide and is associated with
substantial impacts on patient quality of life, morbidity, mortality, and cost to the healthcare …
substantial impacts on patient quality of life, morbidity, mortality, and cost to the healthcare …
Bladder cancer: a review
AT Lenis, PM Lec, K Chamie - Jama, 2020 - jamanetwork.com
Importance Bladder cancer is a common malignancy in women and is the fourth most
common malignancy in men. Bladder cancer ranges from unaggressive and usually …
common malignancy in men. Bladder cancer ranges from unaggressive and usually …
[HTML][HTML] A consensus molecular classification of muscle-invasive bladder cancer
Background Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with
heterogeneous clinical outcomes. Several molecular classifications have been proposed …
heterogeneous clinical outcomes. Several molecular classifications have been proposed …
Best practice in the treatment of nonmuscle invasive bladder cancer
A Anastasiadis, TM de Reijke - Therapeutic advances in …, 2012 - journals.sagepub.com
Bladder carcinoma is the most common malignancy of the urinary tract. Approximately 75–
85% of patients with bladder cancer present with a disease that is confined to the mucosa …
85% of patients with bladder cancer present with a disease that is confined to the mucosa …
BCG-unresponsive non-muscle-invasive bladder cancer: current treatment landscape and novel emerging molecular targets
Urothelial carcinoma (UC), the sixth most common cancer in Western countries, includes
upper tract urothelial carcinoma (UTUC) and bladder carcinoma (BC) as the most common …
upper tract urothelial carcinoma (UTUC) and bladder carcinoma (BC) as the most common …
Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
FC de Jong, TD Laajala, RF Hoedemaeker… - Science translational …, 2023 - science.org
The recommended treatment for patients with high-risk non–muscle-invasive bladder cancer
(HR-NMIBC) is tumor resection followed by adjuvant Bacillus Calmette-Guérin (BCG) …
(HR-NMIBC) is tumor resection followed by adjuvant Bacillus Calmette-Guérin (BCG) …
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
MA Knowles, CD Hurst - Nature reviews cancer, 2015 - nature.com
Urothelial carcinoma of the bladder comprises two long-recognized disease entities with
distinct molecular features and clinical outcome. Low-grade non-muscle-invasive tumours …
distinct molecular features and clinical outcome. Low-grade non-muscle-invasive tumours …
[HTML][HTML] Non-muscle-invasive bladder cancer: An overview of potential new treatment options
Aim This review article summarizes the current clinical practice guidelines around disease
definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer …
definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer …
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
W Choi, B Czerniak, A Ochoa, X Su… - Nature Reviews …, 2014 - nature.com
Whole-genome analyses have revealed that muscle-invasive bladder cancers (MIBCs) are
heterogeneous and can be grouped into basal and luminal subtypes that are highly …
heterogeneous and can be grouped into basal and luminal subtypes that are highly …